EVAX · Evaxion A/S ADR
United States · RS rating 15 · As of 2026-10-14
| Price | 2.80 USD |
|---|---|
| 1-day change | +1.4% |
| RS rating (overall / 1M / 3M / 12M) | 15 / 28 / 32 / 12 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 9 / 17 |
| Industry group (rank) | Medical-Biomed/Biotech (167) |
| EPS growth Q/Q | -300.0% |
| Sales growth Q/Q | -100.0% |
| Distance from 52-week high | +74.6% |
| Market cap (USD) | $35.4M |